ATE117206T1 - Zusammensetzungen und verfahren zur behandlung von magen-darmstörungen. - Google Patents

Zusammensetzungen und verfahren zur behandlung von magen-darmstörungen.

Info

Publication number
ATE117206T1
ATE117206T1 AT88200396T AT88200396T ATE117206T1 AT E117206 T1 ATE117206 T1 AT E117206T1 AT 88200396 T AT88200396 T AT 88200396T AT 88200396 T AT88200396 T AT 88200396T AT E117206 T1 ATE117206 T1 AT E117206T1
Authority
AT
Austria
Prior art keywords
gastrointestinal disorders
methods
compositions
treating
treating gastrointestinal
Prior art date
Application number
AT88200396T
Other languages
English (en)
Inventor
Geoffrey Place
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21816098&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE117206(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Procter & Gamble filed Critical Procter & Gamble
Application granted granted Critical
Publication of ATE117206T1 publication Critical patent/ATE117206T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/345—Nitrofurans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT88200396T 1987-03-09 1988-03-02 Zusammensetzungen und verfahren zur behandlung von magen-darmstörungen. ATE117206T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2359687A 1987-03-09 1987-03-09

Publications (1)

Publication Number Publication Date
ATE117206T1 true ATE117206T1 (de) 1995-02-15

Family

ID=21816098

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88200396T ATE117206T1 (de) 1987-03-09 1988-03-02 Zusammensetzungen und verfahren zur behandlung von magen-darmstörungen.

Country Status (13)

Country Link
US (1) US5407688A (de)
EP (2) EP0282131B1 (de)
JP (1) JP2648328B2 (de)
KR (1) KR970007188B1 (de)
AT (1) ATE117206T1 (de)
AU (2) AU621285B2 (de)
CA (1) CA1312012C (de)
DE (1) DE3852773T2 (de)
DK (1) DK175866B1 (de)
IE (2) IE66367B1 (de)
IL (1) IL85472A (de)
NZ (1) NZ223774A (de)
ZA (1) ZA881678B (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3874917T2 (de) * 1987-03-09 1993-03-04 Procter & Gamble Zusammensetzungen und ihre verwendung zur behandlung von magen-darmstoerungen.
IL85472A (en) * 1987-03-09 1991-06-30 Procter & Gamble Pharmaceutical compositions for treating gastrointestinal disorders
CH679582A5 (de) * 1988-07-18 1992-03-13 Glaxo Group Ltd
AU641903B2 (en) * 1988-10-26 1993-10-07 Glaxo Group Limited Carboxylic acid derivatives
EP0403048A3 (de) * 1989-06-14 1991-01-30 Warner-Lambert Company Medizinische Sucralfat enthaltende Zusammensetzungen und Verfahren zur Herstellung
GB9010039D0 (en) * 1990-05-03 1990-06-27 Reckitt & Colmann Prod Ltd Medicament preparation
KR100193933B1 (ko) * 1990-07-20 1999-06-15 에밀리오 캠포레시, 존 페르구손 비스무트와 폴리아크릴레이트와의 수용성 착체, 이의 제조 방법 및 상기 착체 또는 다른 비스무트염을 함유하는 궤양성 대장염 치료용 약제학적 조성물
GB9018603D0 (en) * 1990-08-24 1990-10-10 Smith Kline French Lab Compositions
WO1992004898A1 (de) * 1990-09-14 1992-04-02 Byk Gulden Lomberg Chemische Fabrik Gmbh Verwendung von pyridylmethylsulfinyl-1h-benzimidazol derivaten zur behandlung durch helicobacter verursachten erkrankungen
US5192752A (en) * 1991-01-14 1993-03-09 The Procter & Gamble Company Swallowable pharmaceutical compositions containing colloidal bismuth subcitrate
GB9120131D0 (en) * 1991-09-20 1991-11-06 Glaxo Group Ltd Medicaments
DK0550083T3 (da) * 1991-12-06 1999-10-11 Glaxo Group Ltd Lægemidler til behandling af inflammatoriske tilstande eller til analgesi og indeholdende et NSAID og ranitidinbismuthcitra
GB9127150D0 (en) * 1991-12-20 1992-02-19 Smithkline Beecham Plc Novel treatment
IL105155A (en) * 1992-04-24 1999-05-09 Astra Ab Combination of a substance with gastric acid secretion inhibiting effect and an acid degradable antibiotic
WO1994028898A1 (en) * 1993-06-15 1994-12-22 Pfizer Inc. H2-antagonists as immune stimulants in bacterial infections of cattle or swine
WO1996014068A1 (de) * 1994-11-07 1996-05-17 Asche Ag Arzneimittel zur behandlung von erkrankungen des magen-darm-traktes
US5861518A (en) * 1994-11-21 1999-01-19 Dekker; Koenraad A. Phthalide compounds and their production process
JP3767831B2 (ja) * 1995-06-14 2006-04-19 木村 健 ヘリコバクター・ピロリ除菌用組成物
AU1117497A (en) * 1995-11-13 1997-06-05 Albany Medical College Analgesic compounds and uses thereof
US5744168A (en) * 1995-12-07 1998-04-28 The Procter & Gamble Company Methods and compositions for the prevention and treatment of gastrointestinal disorders
US6552047B2 (en) 1998-11-17 2003-04-22 Nitromed, Inc. H2 receptor antagonist compounds in combination with nitric oxide donors, compositions and methods of use
CL2004000983A1 (es) 2003-05-08 2005-03-04 Altana Pharma Ag Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y
PE20050150A1 (es) 2003-05-08 2005-03-22 Altana Pharma Ag Una forma de dosificacion que contiene (s)-pantoprazol como ingrediente activo
AU2005239838B2 (en) 2004-05-07 2011-08-11 Takeda Gmbh Pharmaceutical dosage form comprising pellets as well as its manufacturing process
ES2602789T3 (es) 2007-02-09 2017-02-22 Ocera Therapeutics, Inc. Productos intermedios conectores para la síntesis de moduladores macrocíclicos del receptor de la grelina
JP2011178722A (ja) * 2010-03-01 2011-09-15 Synmosa Biopharma Corp ヘリコバクタ−・ピロリ（Ｈ．ｐｙｌｏｒｉ）を除菌する医薬組成物及びその製造方法
EP2601947A1 (de) * 2011-12-05 2013-06-12 Abo Bakr Mohammed Ali Al-Mehdar Kombinationspräparat mit fester Dosierung zur Behandlung von Erkrankungen einhergehend mit Helicobacter pylori

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2218883B1 (de) * 1973-02-28 1976-08-13 Science Union & Cie
US4333922A (en) * 1974-09-12 1982-06-08 Herschler R J Method for the treatment of water-living animals with health modifying agents
CH638975A5 (fr) * 1979-07-27 1983-10-31 Prebuilt Ets Composition medicamenteuse pour le traitement des ulceres gastro-duodenaux.
WO1986005981A1 (en) * 1985-04-18 1986-10-23 Borody Thomas J Treatment of non-ulcer dyspepsia with bismuth salts
ATE79261T1 (de) * 1985-06-13 1992-08-15 Barry James M D Marshall Verfahren zur behandlung von magen-darmstoerungen.
DE3650504T2 (de) * 1985-06-13 1996-10-31 Marshall Barry James Verfahren und Zusammensetzungen zur Behandlung von gastrointestinalen Störungen
US4959384A (en) * 1985-10-24 1990-09-25 Norwich Eaton Pharmaceuticals, Inc. Use of nitrofurantoin for the treatment and prophylaxis of gastrointestinal disorders
IL85472A (en) * 1987-03-09 1991-06-30 Procter & Gamble Pharmaceutical compositions for treating gastrointestinal disorders
DE3874917T2 (de) * 1987-03-09 1993-03-04 Procter & Gamble Zusammensetzungen und ihre verwendung zur behandlung von magen-darmstoerungen.
CH679582A5 (de) * 1988-07-18 1992-03-13 Glaxo Group Ltd
DE3830616A1 (de) * 1988-09-09 1990-03-15 Ruetgerswerke Ag Prophylaktikum fuer fische

Also Published As

Publication number Publication date
JPS63290831A (ja) 1988-11-28
DK127788A (da) 1988-09-10
CA1312012C (en) 1992-12-29
IL85472A (en) 1991-06-30
NZ223774A (en) 1991-02-26
AU621285B2 (en) 1992-03-12
IE66367B1 (en) 1995-12-27
IE880665L (en) 1988-09-09
US5407688A (en) 1995-04-18
JP2648328B2 (ja) 1997-08-27
DK127788D0 (da) 1988-03-09
DE3852773T2 (de) 1995-07-06
DE3852773D1 (de) 1995-03-02
AU1279388A (en) 1988-09-08
AU660645B2 (en) 1995-07-06
ZA881678B (en) 1988-09-07
EP0282131A2 (de) 1988-09-14
IE950632L (en) 1988-09-09
EP0282131B1 (de) 1995-01-18
KR970007188B1 (ko) 1997-05-07
EP0282131A3 (en) 1989-11-15
EP0578965A1 (de) 1994-01-19
KR880011197A (ko) 1988-10-27
AU1030292A (en) 1992-03-05
DK175866B1 (da) 2005-04-18

Similar Documents

Publication Publication Date Title
DE3852773D1 (de) Zusammensetzungen und Verfahren zur Behandlung von Magen-Darmstörungen.
ATE81011T1 (de) Zusammensetzungen und ihre verwendung zur behandlung von magen-darmstoerungen.
DE69109560D1 (de) Fungizide Zusammensetzung zur Behandlung von Saatgut.
ATE114113T1 (de) Verwendung von droloxifen bei der behandlung von knochenerkrankungen.
FI931708A0 (fi) Herbicida substituerade aryl-haloalkylpyrazoler
DE69009684D1 (de) Pharmazeutische Zusammensetzungen zur Behandlung gastrointestinaler Störungen.
ATE209490T1 (de) Substanz p antagonisten zur behandlung von erbrechen
DE3882775D1 (de) Zusammensetzung zur behandlung von parodontaler krankheit.
DK0636027T3 (da) Angiotensin-II-antogonister mod sygdomme forbundet med forringet neuronal ledningshastighed, især diabetisk neuropati
FI873428A7 (fi) Silmälääketieteelliset koostumukset hermodegeneraatioiden hoitoon.
DE69114635D1 (de) 1,3-Diphenyl-2-propin-1-one.
DE3750979D1 (de) 5-Aryl-3H-1,2,4-triazol-3-one und ihre Verwendung in der Behandlung neurodegenerativer Beschwerden.
DE69112743D1 (de) Anlage zur Behandlung von Tierexkrementen.
ATE85184T1 (de) Pestizide zusammensetzungen und verfahren.
IL91152A0 (en) Furylthiazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
GR3034661T3 (en) Use of Selegiline in vetenary medicine.
DE69622005D1 (de) Zusammensetzung zur Vorbeugung und Behandlung von urogenitalen Störungen, die Wismut und eine oder mehrere antimikrobielle Mitteln enthalten
ZA871140B (en) Synergistic chemical compositions for treating salmonellosis
NO982634L (no) Sammensetninger inneholdende vismut og ett eller flere antimikrobielle midler for forebygging og behandling av gastrointestinale forstyrrelser
UA12753A (uk) Спосіб лікуваhhя та профілактики респіраторhих захворюваhь молодhяка сільськогосподарських твариh змішаhої етіології
ATE232736T1 (de) Zusammensetzungen zur vorbeugung und behandlung von urogenitalen störungen, die wismut enthalten
ATE59529T1 (de) Antimikrobielles mittel zur behandlung von bauwerken, baustoffen, textilien, leder, agrarprodukten und/oder nahrungsmitteln.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
RZN Patent revoked